Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Response to "Letter to the Editor concerning: 'A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants'".

Cohen AT, Hill NR, Luo X, Masseria C, Abariga SA, Ashaye AO.

Int J Cardiol. 2019 Nov 28. pii: S0167-5273(19)35800-0. doi: 10.1016/j.ijcard.2019.11.141. [Epub ahead of print] No abstract available.

PMID:
31898985
2.

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients.

Lip GYH, Keshishian A, Li X, Hamilton M, Masseria C, Gupta K, Luo X, Mardekian J, Friend K, Nadkarni A, Pan X, Baser O, Deitelzweig S.

Stroke. 2018 Dec;49(12):2933-2944. doi: 10.1161/STROKEAHA.118.020232. Erratum in: Stroke. 2020 Feb;51(2):e44.

3.

Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban.

Tepper PG, Mardekian J, Masseria C, Phatak H, Kamble S, Abdulsattar Y, Petkun W, Lip GYH.

PLoS One. 2018 Nov 1;13(11):e0205989. doi: 10.1371/journal.pone.0205989. eCollection 2018.

4.

A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants.

Cohen AT, Hill NR, Luo X, Masseria C, Abariga SA, Ashaye AO.

Int J Cardiol. 2018 Oct 15;269:174-181. doi: 10.1016/j.ijcard.2018.06.114. Epub 2018 Jun 30.

5.

Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.

Lopes RD, Steffel J, Di Fusco M, Keshishian A, Luo X, Li X, Masseria C, Hamilton M, Friend K, Gupta K, Mardekian J, Pan X, Baser O, Jones WS.

Am J Med. 2018 Sep;131(9):1075-1085.e4. doi: 10.1016/j.amjmed.2018.05.007. Epub 2018 May 26.

PMID:
29807001
6.

Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.

Lip GYH, Pan X, Kamble S, Kawabata H, Mardekian J, Masseria C, Phatak H.

PLoS One. 2018 Apr 30;13(4):e0195950. doi: 10.1371/journal.pone.0195950. eCollection 2018.

7.

Incidence and Burden of Pertussis Among Infants Less Than 1 Year of Age.

Masseria C, Martin CK, Krishnarajah G, Becker LK, Buikema A, Tan TQ.

Pediatr Infect Dis J. 2017 Mar;36(3):e54-e61. doi: 10.1097/INF.0000000000001440.

8.

Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States.

Lip GY, Pan X, Kamble S, Kawabata H, Mardekian J, Masseria C, Bruno A, Phatak H.

Int J Clin Pract. 2016 Sep;70(9):752-63. doi: 10.1111/ijcp.12863. Epub 2016 Aug 23.

9.

Erratum to: The estimated incidence of pertussis in people aged 50 years old or older in the United States, 2006-2010.

Masseria C, Krishnarajah G.

BMC Infect Dis. 2016 Apr 25;16:181. doi: 10.1186/s12879-016-1518-y. No abstract available.

10.

Vaccine Timeliness: A Cost Analysis of the Potential Implications of Delayed Pertussis Vaccination in the US.

Curran D, Terlinden A, Poirrier JE, Masseria C, Krishnarajah G.

Pediatr Infect Dis J. 2016 May;35(5):542-7. doi: 10.1097/INF.0000000000001071.

PMID:
26835971
11.

The estimated incidence of pertussis in people aged 50 years old in the United States, 2006-2010.

Masseria C, Krishnarajah G.

BMC Infect Dis. 2015 Nov 19;15:534. doi: 10.1186/s12879-015-1269-1. Erratum in: BMC Infect Dis. 2016;16(1):181.

12.

Stroke associated with discontinuation of warfarin therapy for atrial fibrillation.

Spivey CA, Liu X, Qiao Y, Mardekian J, Parker RB, Phatak H, Masseria C, Kachroo S, Abdulsattar Y, Wang J.

Curr Med Res Opin. 2015 Nov;31(11):2021-9. doi: 10.1185/03007995.2015.1082995. Epub 2015 Sep 21.

PMID:
26390258
13.

Mixing of diphtheria, tetanus, and acellular pertussis (DTaP) vaccines in a population of children in managed care.

Masseria C, Buikema AR, Liu F, Krishnarajah G.

Hum Vaccin Immunother. 2015;11(5):1175-83. doi: 10.4161/21645515.2014.985506.

14.

Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.

Talbird SE, Graham J, Mauskopf J, Masseria C, Krishnarajah G.

J Manag Care Spec Pharm. 2015 Jan;21(1):88-99, 99a-c.

15.

Cost-effectiveness of Tdap vaccination of adults aged ≥65 years in the prevention of pertussis in the US: a dynamic model of disease transmission.

McGarry LJ, Krishnarajah G, Hill G, Masseria C, Skornicki M, Pruttivarasin N, Arondekar B, Roiz J, Pelton SI, Weinstein MC.

PLoS One. 2014 Jan 9;9(1):e72723. doi: 10.1371/journal.pone.0072723. eCollection 2014.

16.

Cost-effectiveness analysis of Tdap in the prevention of pertussis in the elderly.

McGarry LJ, Krishnarajah G, Hill G, Skornicki M, Pruttivarasin N, Masseria C, Arondekar B, Pelton SI, Weinstein MC.

PLoS One. 2013 Sep 3;8(9):e67260. doi: 10.1371/journal.pone.0067260. eCollection 2013.

17.

The socio-economic determinants of the health status of Roma in comparison with non-Roma in Bulgaria, Hungary and Romania.

Masseria C, Mladovsky P, Hernández-Quevedo C.

Eur J Public Health. 2010 Oct;20(5):549-54. doi: 10.1093/eurpub/ckq102. Epub 2010 Jul 22.

PMID:
20650945
18.

Equity in access to health care in Italy: a disease-based approach.

Masseria C, Giannoni M.

Eur J Public Health. 2010 Oct;20(5):504-10. doi: 10.1093/eurpub/ckq029. Epub 2010 May 26.

PMID:
20504952
19.

Health inequality: what does it mean and how can we measure it?

Masseria C, Hernández-Quevedo C, Allin S.

Expert Rev Pharmacoecon Outcomes Res. 2010 Apr;10(2):177-86. doi: 10.1586/erp.10.14. Review.

PMID:
20384564
20.

Colorectal cancer in Italy: a review of current national and regional practice on screening and treatment.

Masseria C.

Eur J Health Econ. 2010 Jan;10 Suppl 1:S41-9. doi: 10.1007/s10198-009-0191-0.

PMID:
20012136
21.

Measuring socioeconomic differences in use of health care services by wealth versus by income.

Allin S, Masseria C, Mossialos E.

Am J Public Health. 2009 Oct;99(10):1849-55. doi: 10.2105/AJPH.2008.141499. Epub 2009 Jan 15.

22.

Inequalities in access to medical care by income in developed countries.

van Doorslaer E, Masseria C, Koolman X; OECD Health Equity Research Group.

CMAJ. 2006 Jan 17;174(2):177-83.

23.

Challenges to implementing the national programme for information technology (NPfIT): a qualitative study.

Hendy J, Reeves BC, Fulop N, Hutchings A, Masseria C.

BMJ. 2005 Aug 6;331(7512):331-6.

Supplemental Content

Loading ...
Support Center